Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot...

by Mara Oleszowsky, Matthias F. Seidel
Published 2018-01-01

Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis

by Tim T. A. Bender, Judith Leyens, Julia Sellin, Dmitrij Kravchenko, Rupert Conrad, Martin Mücke, Matthias F. Seidel
Published 2020-10-01

The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis

by Judith Leyens, Tim Th. A. Bender, Martin Mücke, Christiane Stieber, Dmitrij Kravchenko, Christian Dernbach, Matthias F. Seidel
Published 2021-07-01